Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karn Wijarnpreecha

Showing results (131-140 of 314) with videos related to

Pageof 32
Sort By:
Clinical and Molecular Hepatology|July 15, 2025
Rising drug overdose deaths in chronic liver disease in the United States, 2015-2023Donghee Kim, Brittany B Dennis, Pojsakorn Danpanichkul, et al.
Lung|February 25, 2019
Inpatient Prevalence, Expenditures, and Comorbidities of Sarcoidosis: Nationwide Inpatient Sample 2013-2014Patompong Ungprasert, Karn Wijarnpreecha, Wisit Cheungpasitporn, et al.
Clinics and Research in Hepatology and Gastroenterology|April 16, 2018
Association between appendectomy and risk of primary sclerosing cholangitis: A systematic review and meta-analysisKarn Wijarnpreecha, Panadeekarn Panjawatanan, Omar Y Mousa, et al.
Alimentary Pharmacology & Therapeutics|May 16, 2023
Trends in aetiology-based hospitalisation for cirrhosis before and during the COVID-19 pandemic in the United StatesDonghee Kim, Brandon J Perumpail, Karn Wijarnpreecha, et al.
Expert Review of Gastroenterology & Hepatology|February 14, 2024
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United StatesPeter Konyn, Brandon J Perumpail, Karn Wijarnpreecha, et al.
Clinical and Molecular Hepatology|June 5, 2026
Risk Assessment of Cardiovascular Disease-related Mortality in Metabolic Dysfunction-Associated Steatotic Liver DiseaseDonghee Kim, Pojsakorn Danpanichkul, Do Han Kim, et al.
Respirology (Carlton, Vic.)|August 21, 2014
Is the incidence of malignancy increased in patients with sarcoidosis? A systematic review and meta-analysisPatompong Ungprasert, Narat Srivali, Karn Wijarnpreecha, et al.
Joint Bone Spine|March 19, 2020
Inpatient burden and resource utilization of polymyositis and dermatomyositis: A 10-year Study of National Inpatient SamplePatompong Ungprasert, Thapat Wannarong, Wisit Cheungpasitporn, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 16, 2024
The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adultsBrandon J Perumpail, Richie Manikat, Karn Wijarnpreecha, et al.
European Journal of Gastroenterology & Hepatology|May 29, 2019
Acute pancreatitis in end-stage renal disease patients in the USA: a nationwide, propensity score-matched analysisWisit Cheungpasitporn, Charat Thongprayoon, Patompong Ungprasert, et al.
Pageof 32

Showing results (131-140 of 314) with videos related to

Sort By:
Pageof 32
Clinical and Molecular Hepatology|July 15, 2025
Rising drug overdose deaths in chronic liver disease in the United States, 2015-2023Donghee Kim, Brittany B Dennis, Pojsakorn Danpanichkul, et al.
Lung|February 25, 2019
Inpatient Prevalence, Expenditures, and Comorbidities of Sarcoidosis: Nationwide Inpatient Sample 2013-2014Patompong Ungprasert, Karn Wijarnpreecha, Wisit Cheungpasitporn, et al.
Clinics and Research in Hepatology and Gastroenterology|April 16, 2018
Association between appendectomy and risk of primary sclerosing cholangitis: A systematic review and meta-analysisKarn Wijarnpreecha, Panadeekarn Panjawatanan, Omar Y Mousa, et al.
Alimentary Pharmacology & Therapeutics|May 16, 2023
Trends in aetiology-based hospitalisation for cirrhosis before and during the COVID-19 pandemic in the United StatesDonghee Kim, Brandon J Perumpail, Karn Wijarnpreecha, et al.
Expert Review of Gastroenterology & Hepatology|February 14, 2024
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United StatesPeter Konyn, Brandon J Perumpail, Karn Wijarnpreecha, et al.
Clinical and Molecular Hepatology|June 5, 2026
Risk Assessment of Cardiovascular Disease-related Mortality in Metabolic Dysfunction-Associated Steatotic Liver DiseaseDonghee Kim, Pojsakorn Danpanichkul, Do Han Kim, et al.
Respirology (Carlton, Vic.)|August 21, 2014
Is the incidence of malignancy increased in patients with sarcoidosis? A systematic review and meta-analysisPatompong Ungprasert, Narat Srivali, Karn Wijarnpreecha, et al.
Joint Bone Spine|March 19, 2020
Inpatient burden and resource utilization of polymyositis and dermatomyositis: A 10-year Study of National Inpatient SamplePatompong Ungprasert, Thapat Wannarong, Wisit Cheungpasitporn, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 16, 2024
The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adultsBrandon J Perumpail, Richie Manikat, Karn Wijarnpreecha, et al.
European Journal of Gastroenterology & Hepatology|May 29, 2019
Acute pancreatitis in end-stage renal disease patients in the USA: a nationwide, propensity score-matched analysisWisit Cheungpasitporn, Charat Thongprayoon, Patompong Ungprasert, et al.
Pageof 32